IL150031A0 - Benzoic acid esters of oxazolidines having a hydroxyacetylpiperazine substituent - Google Patents

Benzoic acid esters of oxazolidines having a hydroxyacetylpiperazine substituent

Info

Publication number
IL150031A0
IL150031A0 IL15003100A IL15003100A IL150031A0 IL 150031 A0 IL150031 A0 IL 150031A0 IL 15003100 A IL15003100 A IL 15003100A IL 15003100 A IL15003100 A IL 15003100A IL 150031 A0 IL150031 A0 IL 150031A0
Authority
IL
Israel
Prior art keywords
oxazolidines
benzoic acid
acid esters
hydroxyacetylpiperazine
substituent
Prior art date
Application number
IL15003100A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IL150031A0 publication Critical patent/IL150031A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15003100A 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidines having a hydroxyacetylpiperazine substituent IL150031A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17067599P 1999-12-14 1999-12-14
PCT/US2000/032432 WO2001044212A1 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent

Publications (1)

Publication Number Publication Date
IL150031A0 true IL150031A0 (en) 2002-12-01

Family

ID=22620832

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15003100A IL150031A0 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidines having a hydroxyacetylpiperazine substituent

Country Status (26)

Country Link
US (1) US6281210B1 (hu)
EP (1) EP1242395B1 (hu)
JP (1) JP2003516977A (hu)
KR (1) KR20020062332A (hu)
CN (1) CN1390211A (hu)
AR (1) AR026547A1 (hu)
AT (1) ATE288423T1 (hu)
AU (1) AU1805801A (hu)
BR (1) BR0015177A (hu)
CA (1) CA2387047A1 (hu)
CO (1) CO5261527A1 (hu)
CZ (1) CZ20022389A3 (hu)
DE (1) DE60017941T2 (hu)
EA (1) EA200200673A1 (hu)
ES (1) ES2236006T3 (hu)
HU (1) HUP0203787A3 (hu)
IL (1) IL150031A0 (hu)
MX (1) MXPA02005909A (hu)
NO (1) NO20022811L (hu)
PE (1) PE20010851A1 (hu)
PL (1) PL355369A1 (hu)
PT (1) PT1242395E (hu)
SK (1) SK5972002A3 (hu)
TW (1) TW544449B (hu)
WO (1) WO2001044212A1 (hu)
ZA (1) ZA200202953B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
WO2002032857A1 (en) * 2000-10-17 2002-04-25 Pharmacia & Upjohn Company Methods of producing oxazolidinone compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
BR0316483A (pt) 2002-11-21 2005-10-11 Upjohn Co Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
SG166126A1 (en) 2005-10-04 2010-11-29 Bayer Schering Pharma Ag Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US20100210602A1 (en) * 2006-12-12 2010-08-19 The Johns Hopkins University PhoU (PerF), A PERSISTENCE SWITCH INVOLVED IN PERSISTER FORMATION AND TOLERANCE TO MULTIPLE ANTIBIOTICS AND STRESSES AS A DRUG TARGET FOR PERSISTER BACTERIA
WO2009001192A2 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652238A (en) * 1993-11-22 1997-07-29 Pharmacia & Upjohn Company Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
ATE293609T1 (de) * 1997-05-30 2005-05-15 Upjohn Co Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
NO20022811D0 (no) 2002-06-13
HUP0203787A3 (en) 2005-06-28
PL355369A1 (en) 2004-04-19
ATE288423T1 (de) 2005-02-15
PE20010851A1 (es) 2001-08-17
ES2236006T3 (es) 2005-07-16
CO5261527A1 (es) 2003-03-31
SK5972002A3 (en) 2003-01-09
CN1390211A (zh) 2003-01-08
EP1242395A1 (en) 2002-09-25
BR0015177A (pt) 2002-06-18
EP1242395B1 (en) 2005-02-02
NO20022811L (no) 2002-06-13
PT1242395E (pt) 2005-05-31
JP2003516977A (ja) 2003-05-20
CZ20022389A3 (cs) 2002-10-16
WO2001044212A1 (en) 2001-06-21
CA2387047A1 (en) 2001-06-21
DE60017941D1 (de) 2005-03-10
US6281210B1 (en) 2001-08-28
HUP0203787A2 (hu) 2003-07-28
AU1805801A (en) 2001-06-25
EA200200673A1 (ru) 2002-12-26
ZA200202953B (en) 2003-09-23
KR20020062332A (ko) 2002-07-25
AR026547A1 (es) 2003-02-19
TW544449B (en) 2003-08-01
DE60017941T2 (de) 2006-03-30
MXPA02005909A (es) 2002-10-23

Similar Documents

Publication Publication Date Title
IL150031A0 (en) Benzoic acid esters of oxazolidines having a hydroxyacetylpiperazine substituent
SG93823A1 (en) Aryl-acrylic acid esters
EP1189612A4 (en) VLA-4 INHIBITORY COMPOUNDS
ID22013A (id) Senyawa-senyawa ester
EP1219662A4 (en) POLYAMIDSÄUREESTER
HUP0105011A3 (en) Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
IL147216A0 (en) Arylsulfonamido-substituted hydroxamic acid derivatives
ZA9810298B (en) Isothiazole carboxylic acid derivatives
HUP0201766A2 (en) A process for obtaining (nitroxymethyl) phenyl esters of salicylic acid derivatives
HK1047274A1 (zh) 氨基苯甲酸衍生物
IL145953A0 (en) A new inhibitor of carboxypeptidase u
GB9929979D0 (en) Hydroxamic acid derivatives
SI1242395T1 (en) Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent
IL130989A0 (en) Variants of alternative splicing
IL164773A0 (en) Ester derivatives of a decahydroisoquinoline-3-carboxlic acid as analgesics
IL146171A0 (en) A proceess for the purification of diacerein
GB9907082D0 (en) The preparation of carboxylic acid derivatives
AU6145900A (en) A float-rotatable show stand of goods
AU2001289723A1 (en) Novel use of difluoromalonic acid esters
GB9817348D0 (en) Pharmaceutical use of esters
PL358688A1 (en) Carbamic acid esters as inhibitors of factor xa
IL140586A0 (en) α-AMINO ACID PHENYL ESTER DERIVATIVES
PL368419A1 (en) Novel $g(a)-oxygenated or $g(a)-thiolated carboxylic acid phenethylamide derivatives
GB9924911D0 (en) Novel phosphonocarboxylic acid esters
IL144253A0 (en) Crystal polymorphism of aminoethylphenoxyacetic acid derivative